Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Biomedical engineer Jamie Spangler and her team at Johns Hopkins develop innovative treatments for autoimmune disorders, ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Researchers from Analysis Group , a global leader in health economics and outcomes research (HEOR), have co-developed a new framework that leverages findings from clinical trials and real-world ...

Federal funding is enabling biomedical engineer Jamie Spangler and her team to develop innovative treatments for autoimmune ...

Methods We used data from three rheumatoid arthritis (RA) trials (one for main analysis ... the aforementioned complexity and diversity of different approaches to determining ‘success’ has partly led ...

These findings introduce miR-199 and CDK2 as potential targets for new treatments aimed at controlling inflammatory diseases.

A growing body of research suggests that garlic supplementation can lower blood pressure, reduce cholesterol, and enhance ...

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

Galapagos shifts to CAR-T therapy with GLPG5101, targeting pivotal trials by 2026. Click here to find out why I rate GLPG ...

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

Jamie Spangler oversees a lab of 33 scientists at Johns Hopkins who are developing new, targeted treatments that harness the power of the immune ...